Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 5/20 | 0.33 |
| ▸ | CTSS | P25774 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | CTSB | P07858 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Morpholine SCHEMBL28452316 | 0.84 | USP2 (0.31) | CTSSCTSLCTSB | |
| SCHEMBL13966679 | 0.79 | CYP2C9 (0.34) | CTSKALDH1A1MEN1KMT2ACYP2C9 | |
| SCHEMBL7548580 | 0.79 | CYP2C9 (0.34) | CTSKALDH1A1MEN1KMT2ACYP2C9 | |
| SCHEMBL3111041 | 0.79 | ADORA2A (0.40) | ALDH1A1MEN1KMT2ACYP2C9 | |
| SCHEMBL3111039 | 0.79 | ADORA2A (0.40) | ALDH1A1MEN1KMT2ACYP2C9 | |
| SCHEMBL23835986 | 0.79 | ADORA2A (0.40) | ALDH1A1MEN1KMT2ACYP2C9 | |
| SCHEMBL24089780 | 0.77 | ALDH1A1 (0.47) | ALDH1A1MEN1KMT2ACYP2C9 | |
| SCHEMBL21160731 | 0.77 | CYP2C9 (0.33) | CTSKALDH1A1MEN1KMT2ACYP2C9 | |
| SCHEMBL667302 | 0.76 | CYP2C9 (0.33) | ALDH1A1CYP2C9 | |
| SCHEMBL17030773 | 0.75 | ALDH1A1 (0.50) | ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11209437-B2 | Fluorescent probe and preparation method and use thereof | FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY (CN) | 2021-12-28 | — | — | US | disclosed |
| US-20190187144-A1 | FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2019-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190187144-A1 | FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF | HNRNPF, HNRNPUL2, RAB5IF | CTSK 1116/4885CTSS 1562/4885ALDH1A1 3152/4885 |
| US-11209437-B2 | Fluorescent probe and preparation method and use thereof | HNRNPF, HNRNPUL2, RAB5IF | CTSK 1116/4885CTSS 1562/4885ALDH1A1 3152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.